This inventor holds 1 USPTO granted patent. Top assignee: Ranbaxy Laboratories, Inc.. Active years: 1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998
Title: Farhan Ahmed - Innovator in Pharmaceutical Formulations
Introduction
Farhan Ahmed is a notable inventor based in New Delhi, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of effervescent formulations. His innovative approach has led to advancements in the treatment of conditions mediated through histamine H.sub.2 receptors.
Latest Patents
Farhan Ahmed holds a patent for "Effervescent ranitidine formulations." This patent describes an effervescent pharmaceutical composition designed for oral use, which contains a therapeutically effective amount of ranitidine or a physiologically acceptable salt thereof. The formulation includes about 25-70% by weight of disodium citrate and about 20-50% by weight of sodium bicarbonate. Additionally, the composition may contain about 0.5-25% by weight of an edible organic acid, such as fumaric acid. The preferred form of this effervescent composition is a tablet, which may also include various excipients such as glycine, flavoring agents, sweetening agents, binding agents, and lubricants.
Career Highlights
Farhan Ahmed is currently associated with Ranbaxy Laboratories, Inc., where he continues to innovate in the pharmaceutical sector. His work has been instrumental in enhancing the efficacy and patient compliance of medications through improved formulations.
Collaborations
Farhan has collaborated with notable colleagues, including Chetan Rajsharad and Himadri Sen. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Farhan Ahmed's contributions to pharmaceutical formulations exemplify the impact of innovation in healthcare. His patent for effervescent ranitidine formulations showcases his commitment to improving treatment options for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
